Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel

Journal of the American College of Cardiology

Volumn 73, Issue 9, 2019, Pages 1059-1077

  Januzzi, James L ^a   Mahler, Simon A ^b   Christenson, Robert H ^c   Rymer, Jennifer ^d   Newby, L Kristin ^d   Body, Richard ^e   Morrow, David A ^a   Jaffe, Allan S ^f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f MAYO CLINIC   (United States)

Author keywords

laboratory testing; myocardial infarction; troponin

Indexed keywords

TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; TROPONIN;

ACUTE HEART INFARCTION; CHRONIC KIDNEY FAILURE; CONCENTRATION (PARAMETER); DIAGNOSTIC TEST; EDUCATION; EMERGENCY WARD; END STAGE RENAL DISEASE; HEART FAILURE; HEART MUSCLE INJURY; HUMAN; KNOWLEDGE; OUTCOME ASSESSMENT; OUTPATIENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; REVIEW; SENSITIVITY ANALYSIS; BLOOD; CLINICAL DECISION MAKING; HEART INFARCTION; HOSPITAL EMERGENCY SERVICE; PRACTICE GUIDELINE; PROCEDURES;

BIOMARKERS; CLINICAL DECISION-MAKING; EMERGENCY SERVICE, HOSPITAL; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; TROPONIN;

EID: 85062028648     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.12.046     Document Type: Review

References (90)

1. Armbruster, D.A., Pry, T., Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 29 Suppl 1 (2008), S49–S52.
2. Wu, A.H.B., Christenson, R.H., Greene, D.N., et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem 64 (2018), 645–655.
3. Alpert, J.S., Thygesen, K., Antman, E., Bassand, J.P., Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. [published correction appears in J Am Coll Cardiol 2001;37:973] J Am Coll Cardiol 36 (2000), 959–969.
4. Mills, N.L., Churchhouse, A.M., Lee, K.K., et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 305 (2011), 1210–1216.
5. Mills, N.L., Lee, K.K., McAllister, D.A., et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ, 344, 2012, e1533.
6. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in J Am Coll Cardiol 2014;64:2713–4]. J Am Coll Cardiol 64 (2014), e139–e228.
7. Morrow, D.A., Cannon, C.P., Jesse, R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53 (2007), 552–574.
8. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al., on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 72 (2018), 2231–2264.
9. Greenslade, J., Cho, E., Van Hise, C., et al. Evaluating rapid rule-out of acute myocardial infarction using a high-sensitivity cardiac troponin I assay at presentation. Clin Chem 64 (2018), 820–829.
10. Shah, A.S., Anand, A., Sandoval, Y., et al., High-STEACS Investigators. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 386 (2015), 2481–2488.
11. Apple, F.S., Jesse, R.L., Newby, L.K., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 53 (2007), 547–551.
12. Apple, F.S., Sandoval, Y., Jaffe, A.S., Ordonez-Llanos, J., Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 63 (2017), 73–81.
13. Mueller, M., Biener, M., Vafaie, M., et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 58 (2012), 209–218.
14. Keller, T., Zeller, T., Ojeda, F., et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 306 (2011), 2684–2693.
15. Twerenbold, R., Wildi, K., Jaeger, C., et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation 131 (2015), 2041–2050.
16. Huang, H.L., Zhu, S., Wang, W.Q., et al. Diagnosis of acute myocardial infarction in hemodialysis patients with high-sensitivity cardiac troponin T assay. Arch Pathol Lab Med 140 (2016), 75–80.
17. Twerenbold, R., Jaffe, A., Reichlin, T., Reiter, M., Mueller, C., High-sensitive troponin T measurements: what do we gain and what are the challenges?. Eur Heart J 33 (2012), 579–586.
18. Wildi, K., Twerenbold, R., Mueller, C., How acute changes in cardiac troponin concentrations help to handle the challenges posed by troponin elevations in non-ACS-patients. Clin Biochem 48 (2015), 218–222.
19. Reichlin, T., Hochholzer, W., Bassetti, S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361 (2009), 858–867.
20. Twerenbold, R., Boeddinghaus, J., Nestelberger, T., et al. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol 70 (2017), 996–1012.
21. Mueller, C., Biomarkers and acute coronary syndromes: an update. Eur Heart J 35 (2014), 552–556.
22. Cullen, L., Mueller, C., Parsonage, W.A., et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 62 (2013), 1242–1249.
23. Carlton, E.W., Cullen, L., Than, M., Gamble, J., Khattab, A., Greaves, K., A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin. Heart 101 (2015), 1041–1046.
24. Granger, C.B., Goldberg, R.J., Dabbous, O., et al., for the Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 163 (2003), 2345–2353.
25. Meller, B., Cullen, L., Parsonage, W.A., et al. Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients. Int J Cardiol 184 (2015), 208–215.
26. Than, M., Herbert, M., Flaws, D., et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the emergency department? A clinical survey. Int J Cardiol 166 (2013), 752–754.
27. Twerenbold, R., Jaeger, C., Rubini Gimenez, M., et al. Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. Eur Heart J 37 (2016), 3324–3332.
28. Pickering, J.W., Than, M.P., Cullen, L., et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. [published correction appears in Ann Intern Med 2017;167:528] Ann Intern Med 166 (2017), 715–724.
29. Carlton, E., Greenslade, J., Cullen, L., et al. Evaluation of high-sensitivity cardiac troponin I levels in patients with suspected acute coronary syndrome. JAMA Cardiol 1 (2016), 405–412.
30. Pickering, J.W., Greenslade, J.H., Cullen, L., et al. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. Heart 102 (2016), 1270–1278.
31. Chapman, A.R., Anand, A., Boeddinghaus, J., et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation 135 (2017), 1586–1596.
32. Reichlin, T., Cullen, L., Parsonage, W.A., et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med 128 (2015), 369–379.e4.
33. Peacock, W.F., Baumann, B.M., Bruton, D., et al. Efficacy of high-sensitivity troponin T in identifying very-low-risk patients with possible acute coronary syndrome. JAMA Cardiol 3 (2018), 104–111.
34. Boeddinghaus, J., Reichlin, T., Cullen, L., et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction by use of high-sensitivity cardiac troponin I. Clin Chem 62 (2016), 494–504.
35. Wildi, K., Cullen, L., Twerenbold, R., et al. Direct comparison of 2 rule-out strategies for acute myocardial infarction: 2-h accelerated diagnostic protocol vs 2-h algorithm. Clin Chem 63 (2017), 1227–1236.
36. McRae, A.D., Innes, G., Graham, M., et al. Comparative evaluation of 2-hour rapid diagnostic algorithms for acute myocardial infarction using high-sensitivity cardiac troponin T. Can J Cardiol 33 (2017), 1006–1012.
37. Roffi, M., Patrono, C., Collet, J.P., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37 (2016), 267–315.
38. Reichlin, T., Schindler, C., Drexler, B., et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 172 (2012), 1211–1218.
39. Reichlin, T., Twerenbold, R., Wildi, K., et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ 187 (2015), E243–E252.
40. Rubini Gimenez, M., Twerenbold, R., Jaeger, C., et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med 128 (2015), 861–870.e4.
41. Jaeger, C., Wildi, K., Twerenbold, R., et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J 171 (2016), 92–102.e1–5.
42. Twerenbold, R., Neumann, J.T., Sorensen, N.A., et al. Prospective validation of the 0/1-h algorithm for early diagnosis of myocardial infarction. J Am Coll Cardiol 72 (2018), 620–632.
43. Boeddinghaus, J., Nestelberger, T., Twerenbold, R., et al. Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction. Eur Heart J 39 (2018), 3780–3794.
44. Andruchow, J.E., Kavsak, P.A., McRae, A.D., Contemporary emergency department management of patients with chest pain: a concise review and guide for the high-sensitivity troponin era. Can J Cardiol 34 (2018), 98–108.
45. Bjurman, C., Larsson, M., Johanson, P., et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol 62 (2013), 1231–1238.
46. Wildi, K., Nelles, B., Twerenbold, R., et al. Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. Am Heart J 181 (2016), 16–25.
47. Badertscher, P., Boeddinghaus, J., Twerenbold, R., et al., for the APACE Investigators. Direct comparison of the 0/1h and 0/3h algorithms for early rule-out of acute myocardial infarction. Circulation 137 (2018), 2536–2538.
48. Antman, E.M., Cohen, M., Bernink, P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000), 835–842.
49. Pollack, C.V. Jr., Sites, F.D., Shofer, F.S., Sease, K.L., Hollander, J.E., Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med 13 (2006), 13–18.
50. Hess, E.P., Agarwal, D., Chandra, S., et al. Diagnostic accuracy of the TIMI risk score in patients with chest pain in the emergency department: a meta-analysis. CMAJ 182 (2010), 1039–1044.
51. Pickering, J.W., Flaws, D., Smith, S.W., et al. A risk assessment score and initial high-sensitivity troponin combine to identify low risk of acute myocardial infarction in the emergency department. Acad Emerg Med 25 (2018), 434–443.
52. Than, M., Cullen, L., Aldous, S., et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol 59 (2012), 2091–2098.
53. Mahler, S.A., Miller, C.D., Litt, H.I., Gatsonis, C.A., Snyder, B.S., Hollander, J.E., Performance of the 2-hour accelerated diagnostic protocol within the American College of Radiology Imaging Network PA 4005 cohort. Acad Emerg Med 22 (2015), 452–460.
54. Than, M., Aldous, S., Lord, S.J., et al. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med 174 (2014), 51–58.
55. Six, A.J., Backus, B.E., Kelder, J.C., Chest pain in the emergency room: value of the HEART score. Neth Heart J 16 (2008), 191–196.
56. Van Den Berg, P., Body, R., The HEART score for early rule out of acute coronary syndromes in the emergency department: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 7 (2018), 111–119.
57. Mahler, S.A., Hiestand, B.C., Goff, D.C. Jr., Hoekstra, J.W., Miller, C.D., Can the HEART score safely reduce stress testing and cardiac imaging in patients at low risk for major adverse cardiac events?. Crit Pathw Cardiol 10 (2011), 128–133.
58. Mahler, S., Lenoir, K., Wells, B., et al. Safely identifying emergency department patients with acute chest pain for early discharge: HEART pathway accelerated diagnostic protocol. Circulation 138 (2018), 2456–2468.
59. Body, R., Carlton, E., Sperrin, M., et al. Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J 34 (2017), 349–356.
60. Haider, D.G., Klemenz, T., Fiedler, G.M., Nakas, C.T., Exadaktylos, A.K., Leichtle, A.B., High sensitive cardiac troponin T: testing the test. Int J Cardiol 228 (2017), 779–783.
61. Than, M., Flaws, D., Sanders, S., et al. Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol. Emerg Med Australas 26 (2014), 34–44.
62. Flaws, D., Than, M., Scheuermeyer, F.X., et al. External validation of the emergency department assessment of chest pain score accelerated diagnostic pathway (EDACS-ADP). Emerg Med J 33 (2016), 618–625.
63. Stopyra, J.P., Miller, C.D., Hiestand, B.C., et al. Performance of the EDACS-accelerated diagnostic pathway in a cohort of US patients with acute chest pain. Crit Pathw Cardiol 14 (2015), 134–138.
64. Than, M.P., Pickering, J.W., Dryden, J.M., et al., on behalf of the ICare-ACS Implementation Group. ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): a study of cross-system implementation of a national clinical pathway. Circulation 137 (2018), 354–363.
65. Amsterdam, E.A., Kirk, J.D., Bluemke, D.A., et al. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. [published correction appears in Circulation 2010;122:e500–1] Circulation 122 (2010), 1756–1776.
66. Hermann, L.K., Weingart, S.D., Duvall, W.L., Henzlova, M.J., The limited utility of routine cardiac stress testing in emergency department chest pain patients younger than 40 years. Ann Emerg Med 54 (2009), 12–16.
67. Hermann, L.K., Newman, D.H., Pleasant, W.A., et al. Yield of routine provocative cardiac testing among patients in an emergency department-based chest pain unit. JAMA Intern Med 173 (2013), 1128–1133.
68. Sandhu, A.T., Heidenreich, P.A., Bhattacharya, J., Bundorf, M.K., Cardiovascular testing and clinical outcomes in emergency department patients with chest pain. JAMA Intern Med 177 (2017), 1175–1182.
69. Ferencik, M., Mayrhofer, T., Lu, M.T., et al. High-sensitivity cardiac troponin I as a gatekeeper for coronary computed tomography angiography and stress testing in patients with acute chest pain. Clin Chem 63 (2017), 1724–1733.
70. Shah, A.S.V., Anand, A., Strachan, F.E., et al., on behalf of the High-STEACS Investigators. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet 392 (2018), 919–928.
71. Smilowitz, N.R., Gupta, N., Guo, Y., Berger, J.S., Bangalore, S., Perioperative acute myocardial infarction associated with non-cardiac surgery. Eur Heart J 38 (2017), 2409–2417.
72. Devereaux, P.J., Biccard, B.M., Chan, M.T.V., High-sensitivity troponin levels, ischemia, and mortality: reply. JAMA, 318, 2017, 865.
73. Landesberg, G., Mosseri, M., Zahger, D., et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 37 (2001), 1839–1845.
74. Landesberg, G., Shatz, V., Akopnik, I., et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 42 (2003), 1547–1554.
75. Gualandro, D.M., Campos, C.A., Calderaro, D., et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis 222 (2012), 191–195.
76. Stevens, P.E., Levin, A., Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline. Ann Intern Med 158 (2013), 825–830.
77. Smilowitz, N.R., Gupta, N., Guo, Y., Mauricio, R., Bangalore, S., Management and outcomes of acute myocardial infarction in patients with chronic kidney disease. Int J Cardiol 227 (2017), 1–7.
78. deFilippi, C., Seliger, S.L., Kelley, W., et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem 58 (2012), 1342–1351.
79. Parikh, R.H., Seliger, S.L., deFilippi, C.R., Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem 48 (2015), 247–253.
80. Chen, M., Gerson, H., Eintracht, S., Nessim, S.J., MacNamara, E., Effect of hemodialysis on levels of high-sensitivity cardiac troponin T. Am J Cardiol 120 (2017), 2061–2064.
81. Twerenbold, R., Badertscher, P., Boeddinghaus, J., et al. 0/1-Hour triage algorithm for myocardial infarction in patients with renal dysfunction. Circulation 137 (2018), 436–451.
82. Januzzi, J.L. Jr., Filippatos, G., Nieminen, M., Gheorghiade, M., Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J 33 (2012), 2265–2271.
83. Aimo, A., Januzzi, J.L. Jr., Vergaro, G., et al. Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis. Circulation 137 (2018), 286–297.
84. Motiwala, S.R., Gaggin, H.K., Gandhi, P.U., et al. Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure. J Cardiovasc Transl Res 8 (2015), 164–172.
85. Ford, I., Shah, A.S., Zhang, R., et al. High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol 68 (2016), 2719–2728.
86. deFilippi, C.R., de Lemos, J.A., Tkaczuk, A.T., et al. Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. J Am Coll Cardiol 60 (2012), 2539–2547.
87. Omland, T., White, H.D., State of the Art: Blood biomarkers for risk stratification in patients with stable ischemic heart disease. Clin Chem 63 (2017), 165–176.
88. Willeit, P., Welsh, P., Evans, J.D.W., et al. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. J Am Coll Cardiol 70 (2017), 558–568.
89. de Lemos, J.A., Drazner, M.H., Omland, T., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population [published correction appears in JAMA 2011;305:1200]. JAMA 304 (2010), 2503–2512.
90. Omland, T., Cardiac troponins: a tool for a personalized medicine strategy in stable coronary artery disease?. J Am Coll Cardiol 63 (2014), 355–357.